1
|
Blanchet I, Michel F, Tardieu C, Camoin A. Difficulties experienced by dentists and orthodontists regarding ethical issues when announcing the diagnosis of a rare oral disease: a qualitative study in Marseille, France. Eur Arch Paediatr Dent 2024; 25:169-179. [PMID: 38457081 DOI: 10.1007/s40368-024-00864-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Accepted: 01/03/2024] [Indexed: 03/09/2024]
Abstract
PURPOSE It is traditionally considered that breaking bad news to patients does not represent a cause for concern for dental professionals. However, there are situations where they will be confronted with this task, as in the case of rare dental diseases. Little information is available regarding the feelings of healthcare professionals on this subject. There are no qualitative studies that explore how a diagnosis of oligodontia is announced to patients by dentists and orthodontists. The aim of our study is to explore the difficulties and ethical issues experienced by dental health professionals when they have to announce a diagnosis of oligodontia to a patient and their family. METHODS This study relied on a qualitative research method using focus groups of dentists and orthodontists and a thematic analysis procedure. RESULTS The difficulties experienced could be summarised within five topics: organisational difficulties, difficulties with the management of dental treatment and with the administrative management associated with this anomaly, difficulties with the content of the announcement, and relational difficulties. These could be grouped in two categories: practical difficulties and ethical difficulties. CONCLUSION This survey allowed us to understand the difficulties encountered by dentists and orthodontists when announcing oligodontia. The participants felt uncomfortable with this task and were under stress. They reported difficulties in delivering the medical information and in adapting to the message. It is essential that dental professionals develop skills in medical communication.
Collapse
Affiliation(s)
- I Blanchet
- APHM Timone Hospital, 264 Rue Saint Pierre, 13005, Marseille, France.
- Medical and Paramedical Sciences Faculty, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France.
- ADES CNRS EFS, UMR 7268, Aix-Marseille University, 51 Bd Pierre Dramard, 13344, Marseille, France.
| | - F Michel
- APHM Timone Hospital, 264 Rue Saint Pierre, 13005, Marseille, France
- Medical and Paramedical Sciences Faculty, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France
- ADES CNRS EFS, UMR 7268, Aix-Marseille University, 51 Bd Pierre Dramard, 13344, Marseille, France
| | - C Tardieu
- APHM Timone Hospital, 264 Rue Saint Pierre, 13005, Marseille, France
- Medical and Paramedical Sciences Faculty, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France
- ADES CNRS EFS, UMR 7268, Aix-Marseille University, 51 Bd Pierre Dramard, 13344, Marseille, France
| | - A Camoin
- APHM Timone Hospital, 264 Rue Saint Pierre, 13005, Marseille, France
- Medical and Paramedical Sciences Faculty, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France
- ADES CNRS EFS, UMR 7268, Aix-Marseille University, 51 Bd Pierre Dramard, 13344, Marseille, France
| |
Collapse
|
2
|
Farajallah M, Larid G, Michel F, Karsenty G, Lechevallier E, Boissier R. Practices and knowledge of general practitioners on erectile dysfunction: A practice survey. Fr J Urol 2024; 34:102591. [PMID: 38412649 DOI: 10.1016/j.fjurol.2024.102591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 12/24/2023] [Accepted: 01/22/2024] [Indexed: 02/29/2024]
Abstract
INTRODUCTION Erectile dysfunction (ED) is a common and underestimated sexual disorder. This sexual concern, which should raise the suspicion of an underlying coronary artery disease, is rarely broached by general practitioners (GPs). The aim of this work was to establish an inventory of the practices and knowledge of general practitioners when faced with a case of ED. METHODS This survey is a descriptive cross-sectional epidemiological study targeting GPs' practice. Answers were collected through a self-questionnaire, "KIKI SAIT?", online that explored: demographic data, level of practice and theoretical knowledge regarding ED. RESULTS One hundred and seventy-seven GPs took part in this study. Regarding their practice, 80.2% of doctors expected the patient to bring up the subject. Few clinicians managed ED according to recommendations of the French Association of Urology. More than 30% referred the patient to a urologist, cardiologist or endocrinologist. In total, 57.6% of practitioners prescribed a phosphodiesterase 5 inhibitor (PDE5I) as first-line treatment. Regarding their knowledge, 67.8% of doctors considered their level of knowledge about PDE5I to be poor, 96.6% about intracavernosal injections, 88.7% about vacuum devices and 91% about penis rings. The main obstacle retained was the lack of medical knowledge (71.2%). Clinicians who rarely consulted for ED were less confident in explaining possible treatments (25/63 versus 18/113, P<0.001). CONCLUSION Strengthening initial training and providing a practical algorithm for the management of ED could be useful to help general practitioners detect ED, which could be a sentinel of coronary heart disease. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- Maeva Farajallah
- Department of Urological Surgery and Renal Transplantation, Conception Hospital, Aix-Marseille University, Marseille, France.
| | - Guillaume Larid
- Rheumatology Department, Poitiers Hospital, University of Poitiers, Poitiers, France
| | - Floriane Michel
- Department of Urological Surgery and Renal Transplantation, Conception Hospital, Aix-Marseille University, Marseille, France
| | - Gilles Karsenty
- Department of Urological Surgery and Renal Transplantation, Conception Hospital, Aix-Marseille University, Marseille, France
| | - Eric Lechevallier
- Department of Urological Surgery and Renal Transplantation, Conception Hospital, Aix-Marseille University, Marseille, France
| | - Romain Boissier
- Department of Urological Surgery and Renal Transplantation, Conception Hospital, Aix-Marseille University, Marseille, France
| |
Collapse
|
3
|
Faure A, Haddad M, Pinol J, Merrot T, Guys JM, Michel F, Karsenty G. Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population. World J Urol 2023; 41:2767-2774. [PMID: 37642679 DOI: 10.1007/s00345-023-04550-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 07/21/2023] [Indexed: 08/31/2023] Open
Abstract
PURPOSE To present our initial experience with periurethral adjustable continence therapy (ACT™) for urinary incontinence due to intrinsic sphincter deficiency (ISD) in children. METHODS This is an approved prospective non-randomized pilot study (NCT03351634) aiming to treat children born with spinal dysraphism (SD) or exstrophy epispadias complex (EEC) with ACT™. Endpoints were patient-reported changes in daily pad count, 24-h Pad test and complications. RESULTS Since April 2018, 13 children (six girls, seven boys) were implanted at the median age of 12 years (5-16). The etiology of incontinence was neurogenic ISD (7/13, 54%) and EEC (6/13, 46%). After ACT™ implantation, continence (no pad or 1 security pad/day) was achieved in 9(69%) patients (5/7 SD, 4/6 EEC). Additionally, two (15%) patients had a significant improvement (decreasing Pad test from 1049 to 310 g at 3 months). One patient (7%) had no improvement. Results were stable at 21 months (6-43) of follow-up. Mean final balloon volume was 2.89 ml (± 0.85) with a median of 3 fillings to obtain continence. We had four revisions due to cutaneous port erosion (n = 3) and balloon migration (n = 1) and two definitive explantations. PinQ score was significantly improved (47 vs 40.5 with balloon, p = ns). Neither degradation of the upper urinary tract nor cystomanometric changes have been observed at 6 and 12 months postoperatively. CONCLUSION Urinary incontinence due to ISD owing to EEC or SD can be successfully treated with ACT™ periurethral balloons. Given the minimal invasiveness of this therapy, it might be a first-line option treatment in children with complex stress urinary incontinence.
Collapse
Affiliation(s)
- Alice Faure
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France.
- Medicine Faculty, Aix-Marseille University, Marseille, France.
| | - Mirna Haddad
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France
| | - Jessica Pinol
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France
- Medicine Faculty, Aix-Marseille University, Marseille, France
| | - Thierry Merrot
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France
- Medicine Faculty, Aix-Marseille University, Marseille, France
| | - Jean-Michel Guys
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France
- Medicine Faculty, Aix-Marseille University, Marseille, France
| | - Floriane Michel
- APHM, Department of Adult Urology and Kidney Transplantation, CHU La Conception, Marseille, France
- Medicine Faculty, Aix-Marseille University, Marseille, France
| | - Gilles Karsenty
- APHM, Department of Adult Urology and Kidney Transplantation, CHU La Conception, Marseille, France
- Medicine Faculty, Aix-Marseille University, Marseille, France
| |
Collapse
|
4
|
Truong XQ, Bakali Issaui Z, Gaillet S, Boissier R, Gondran-Tellier B, Delporte V, Lechevallier E, Karsenty G, Michel F. [Bladder augmentation in the era of botulinum toxin: Indications and results]. Prog Urol 2023; 33:547-554. [PMID: 37666743 DOI: 10.1016/j.purol.2023.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 07/23/2023] [Accepted: 07/25/2023] [Indexed: 09/06/2023]
Abstract
AIM To determine the surgical indication and results of bladder augmentation (BA) during the last decade in a neurourology center in the era of intradetrusor botulinum toxin injection. MATERIAL We conducted a retrospective study that included patients with BA between January 1, 2012 and December 31, 2022 in our centre. We collected pre-operative demographic, clinical, and urodynamic data, BA indication, and associated procedures. We analyzed early and late complications as well as continence and postoperative voiding mode in patients with first BA in a neurological pathology context. RESULTS We performed 77 BA over the study period. The main indication was neurogenic overactive bladder, which was secondarily resistant to botulinum toxin. The main associated procedure was continent cutaneous diversion (n=31, 57.4%). Among patients who had a first BA for neurogenic bladder, 34 patients had early complications (50%) including 12 patients with≥Clavien 3 complications (17.6%). After a median follow-up of 33 [14; 55] months, 23 patients had late complications (33.8%) and 59 patients had complete continence (86.8%). CONCLUSION In the era of botulinum toxin, the main indication of BA is the secondary failure of botulinum toxin for overactive neurogenic bladder. The BA provided continence in 86.8% of patients. It remains however an intervention with a significant rate of severe complications whose indication must be discussed by a multidisciplinary team. LEVEL OF EVIDENCE Weak.
Collapse
Affiliation(s)
- X Q Truong
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - Z Bakali Issaui
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - S Gaillet
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - R Boissier
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - B Gondran-Tellier
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - V Delporte
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - E Lechevallier
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - G Karsenty
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France
| | - F Michel
- CCA d'urologie, service d'urologie et de transplantation rénale, hôpital de la Conception, Assistance publique des Hôpitaux de Marseille, Marseille, France.
| |
Collapse
|
5
|
Hitzeroth J, van der Bijl P, Michel F, Meel R, Cupido BJ, Klug E. SA Heart consensus statement on closure of patent foramen ovale 2021. Cardiovasc J Afr 2023; 34:35-39. [PMID: 35687070 PMCID: PMC10392800 DOI: 10.5830/cvja-2022-009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2021] [Accepted: 02/07/2022] [Indexed: 06/07/2023] Open
Abstract
A patent foramen ovale (PFO) is associated with numerous clinical conditions. The most severe of these is cryptogenic stroke. This consensus statement aims to provide a clinical guideline on which patients should be offered PFO closure.
Collapse
Affiliation(s)
- J Hitzeroth
- Medical School, University of Cape Town, Cape Town, South Africa
| | | | - F Michel
- Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - R Meel
- Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - B J Cupido
- Medical School, University of Cape Town, Cape Town, South Africa
| | - E Klug
- Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
| |
Collapse
|
6
|
Dauger S, Blanot S, Deho A, Beaux J, Bonnin F, Bordet F, Cremer R, Dupont S, Klusiewicz A, Lafargue A, Lemains M, Michel F, Quéré R, Blanquat LDS, Samyn M, Saulnier ML, Temper L, Merchaoui Z, Roux BGL. Organ donation by Maastricht-III pediatric patients: Recommendations of the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) and Association des Anesthésistes Réanimateurs Pédiatriques d'Expression Française (ADARPEF). Part II: Specific organizational and technical considerations. Arch Pediatr 2022; 29:509-515. [PMID: 36055866 DOI: 10.1016/j.arcped.2022.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Revised: 05/04/2022] [Accepted: 06/18/2022] [Indexed: 06/15/2023]
Abstract
A panel of pediatric experts met to develop recommendations on the technical requirements specific to pediatric controlled donation after planned withdrawal of life-sustaining therapies (Maastricht category III). The panel recommends following the withdrawal of life-sustaining therapies protocol usually applied in each unit, which may or may not include immediate extubation. The organ retrieval process should be halted if death does not occur within 3 h of life-support discontinuation. Circulatory arrest is defined as loss of pulsatile arterial pressure and should be followed by a 5-min no-touch observation period. Death is declared based on a list of clinical criteria assessed by two senior physicians. The no-flow time should be no longer than 30, 45, and 90 min for the liver, kidneys, and lungs, respectively. At present, the panel does not recommend pediatric heart donation after death by circulatory arrest. The mean arterial pressure cutoff that defines the start of the functional warm ischemia (FWI) phase is 45 mmHg in patients older than 5 years and/or weighing more than 20 kg. The panel recommends normothermic regional perfusion in these patients. The FWI phase should not exceed 30 and 45 min for retrieving the pancreas and liver, respectively. There is no time limit to the FWI phase for the lungs and kidneys. The panel recommends routine sharing of experience with Maastricht-III donation among all healthcare institutions involved in order to ensure optimal outcome assessment and continuous discussion on the potential difficulties, notably those related to the management of normothermic regional perfusion in small children.
Collapse
Affiliation(s)
- S Dauger
- Service de Médecine Intensive-Réanimation Pédiatriques, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris, Université de Paris, France; Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Centre Hospitalier Universitaire de Lille, Université de Lille, France.
| | - S Blanot
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris, France; Service d'Anesthésie-Réanimation Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris-Cité, France
| | - A Deho
- Service de Médecine Intensive-Réanimation Pédiatriques, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris, Université de Paris, France; Coordination Hospitalière de Prélèvements d'Organes, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris, Université de Paris-Cité, France
| | - J Beaux
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Université de Marseille, France
| | - F Bonnin
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris, France
| | - F Bordet
- Service de Réanimation Médico-Chirurgicale Pédiatrique, Hôpital Femme-Mère-Enfant, Hôpitaux Civils de Lyon, Université de Lyon, France
| | - R Cremer
- Espace de réflexion éthique régional des Hauts-de-France, Centre Hospitalier Universitaire de Lille, Université de Lille, France; Service de Réanimation et Surveillance Continue Pédiatriques, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, Université de Lille, France
| | - S Dupont
- Coordination Hospitalière de Prélèvements d'Organes, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris, Université de Paris-Cité, France
| | - A Klusiewicz
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris-Saclay, France
| | - A Lafargue
- Service d'Anesthésie Réanimation Pédiatrique, Hôpital Jeanne de Flandres, Centre Hospitalier Régional Universitaire de Lille, Université de Lille, France
| | - M Lemains
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris-Saclay, France
| | - F Michel
- Service d'Anesthésie Réanimation Pédiatrique, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Université de Marseille, France
| | - R Quéré
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris, France
| | - L de Saint Blanquat
- Service de Réanimation Médico-Chirurgicale Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris-Cité, France
| | - M Samyn
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris-Saclay, France
| | - M-L Saulnier
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital Mère-Enfant, Centre Hospitalier Universitaire de Nantes, Université de Nantes, France
| | - L Temper
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Université de Lyon, France
| | - Z Merchaoui
- Coordination Hospitalière de Prélèvements d'Organes et de Tissus, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris-Saclay, France; Service de Réanimation Pédiatrique et de Médecine Néonatale, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris-Saclay, France
| | - B Gaillard-Le Roux
- Service de Réanimation Médico-Chirurgicale Pédiatrique, Hôpital Mère-Enfant, Centre Hospitalier Universitaire de Nantes, Université de Nantes, France
| |
Collapse
|
7
|
Long Depaquit T, Michel F, Gaillet S, Savoie PH, Karsenty G. [Home uroflowmetry technics and clinical relevance: A narrative review]. Prog Urol 2022; 32:1531-1542. [PMID: 35961806 DOI: 10.1016/j.purol.2022.07.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Revised: 06/12/2022] [Accepted: 07/10/2022] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Urine flowmetry (UF) is a key non-invasive urodynamic test for the evaluation of the voiding phase in patients with lower urinary tract symptoms (LUTS). Traditional free urodynamic testing (FUT) performed on a one-time basis in the office is limited by difficulty in capturing normal voiding and high intrapatient variability in urine flow parameters. Home measurement of urine flow by the patient could be a way to obtain multiple data in real-life conditions, addressing its limitations. The objective of this article was to review the literature on the different techniques of home uroflowmetry (HUF) and their clinical interest in comparison with FUT. MATERIAL AND METHODS A search on the PubMed database using the key words "Urodynamics, Uroflowmetry, non-invasive urodynamics, Ambulatory urodynamics, bladder outlet obstruction, male LUTS" was performed to find articles in English or French that had been published with no time limit and March 2022. The sorting by reading the abstract allowed the selection of all articles describing and/or evaluating a HUF technique that were read entirely according to the same collection grid to propose a narrative synthesis. RESULTS Thirty-one articles were identified, selected, and analyzed. Simple and inexpensive techniques by timing or use of funnels reliably and reproducibly estimate the average and maximum urine flow in relation to the FUT, without providing a complete flow curve. More sophisticated electronic or sonometric methods, some using connected mobile applications, present results that are more consistent with ICS recommendations for flow measurement. With the possibility of studying the average of several values of the maximum urinary flow (Qmax) captured during micturition in physiological conditions, some studies suggest a gain in diagnostic value in the evaluation of the emptying phase and lower urinary tract symptoms in men. However, the literature is sparse, old and the clinical benefits are not yet proven. CONCLUSION There is a wide range of techniques for measuring urine flow in the patient's home, all of which aim to fill the gaps in conventional urine flow measurement. Further studies are needed to demonstrate the acceptability of this type of measurement by patients, the existence of a real clinical benefit, to assess the cost/benefit balance and finally to define a possible place for home uroflowmetry in daily practice, compared with traditional free flowmetry and invasive urodynamics (pressure-flow test).
Collapse
Affiliation(s)
- T Long Depaquit
- Service d'urologie, HIA Sainte-Anne, 2 boulevard Sainte-Anne BP600, 83000 Toulon, France; Service d'urologie et de transplantation rénale, hôpital de La Conception, AP-HM, Marseille, France; Aix-Marseille université, Marseille, France.
| | - F Michel
- Service d'urologie et de transplantation rénale, hôpital de La Conception, AP-HM, Marseille, France; Aix-Marseille université, Marseille, France
| | - S Gaillet
- Service d'urologie et de transplantation rénale, hôpital de La Conception, AP-HM, Marseille, France
| | - P-H Savoie
- Service d'urologie, HIA Sainte-Anne, 2 boulevard Sainte-Anne BP600, 83000 Toulon, France
| | - G Karsenty
- Service d'urologie et de transplantation rénale, hôpital de La Conception, AP-HM, Marseille, France; Aix-Marseille université, Marseille, France
| |
Collapse
|
8
|
Gaillard-Le Roux B, Cremer R, de Saint Blanquat L, Beaux J, Blanot S, Bonnin F, Bordet F, Deho A, Dupont S, Klusiewicz A, Lafargue A, Lemains M, Merchaoui Z, Quéré R, Samyn M, Saulnier ML, Temper L, Michel F, Dauger S. Organ donation by Maastricht-III pediatric patients: Recommendations of the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) and Association des Anesthésistes Réanimateurs Pédiatriques d'Expression Française (ADARPEF) Part I: Ethical considerations and family care. Arch Pediatr 2022; 29:502-508. [DOI: 10.1016/j.arcped.2022.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2022] [Revised: 05/04/2022] [Accepted: 06/18/2022] [Indexed: 11/27/2022]
|
9
|
Cancrini F, Michel F, Cussenot O, Alshehhi H, Comperat E, Phé V. Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors? World J Urol 2022; 40:1949-1959. [PMID: 35091808 DOI: 10.1007/s00345-022-03941-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 01/10/2022] [Indexed: 12/13/2022] Open
Abstract
PURPOSE The aim of our study was to evaluate and compare the expression of different immunohistochemical markers in Bladder Carcinomas (BC) in patients with Neurogenic Bladder (NB) and Urinary Schistosomiasis (US) infection. MATERIALS AND METHODS We collected tissue samples from patients with Neurogenic Bladder and Bladder Carcinoma (NBC Group) and from patients with Urinary Schistosomiasis infection and Bladder Carcinoma (SBC Group). We compared to these two groups to control samples from resection from patients with Urinary Schistosomiasis without Bladder Carcinoma (US Group); we also investigate patients' characteristics according to urothelial transitional cell carcinoma (TCC), and squamous cell carcinoma (SCC) histopathological differentiation. The expression of markers in all groups (CK7, CK14, CK20, FoxP3, GATA3, STAG2, CD3, CD8, Ki67, and P53) was analyzed using immunohistochemistry of tissue micro-array sections (TMA). RESULTS Overall, 136 patients were included in the study (n = 72 in the NBC group, n = 33 in the SBC group, and n = 31 in the US group). In the TCC subgroup, the expression of CK7, CK14, CK20, and Ki67 was significantly higher compared to US controls (p 0.002; p < 0.001; p 0.036; p < 0.001). In the SCC subgroup, the expression of CK7, CK14, and CK20 was significantly higher compared to US controls (p 0.007; p < 0.001; p 0.005). Both in TCC and SCC subgroups, no difference in the expression of any tested markers was found comparing NBC and SBC groups. In US group, a significant higher expression of STAG2 was found compared to SCC subgroup (p 0.005). CONCLUSION Based on our results, the profile of immunohistochemical biomarkers' expression in both NBC and SBC groups is similar.
Collapse
Affiliation(s)
- Fabiana Cancrini
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza Univeristà di Roma, Sant 'Andrea University Hospital, Via di Grottarossa 1035, 00189, Rome, Italy. .,Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
| | - Floriane Michel
- Department of Urology and Kidney Transplantation, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.,Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Olivier Cussenot
- Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Hussa Alshehhi
- Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Pathology, Tenon Hospital, AP-HP. Sorbonne University, Paris, France
| | - Eva Comperat
- Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Pathology, Tenon Hospital, AP-HP. Sorbonne University, Paris, France
| | - Véronique Phé
- Sorbonne University, GRC n°5, ONCOTYPE-URO, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
10
|
Boucheron T, Lechevallier E, Gondran-Tellier B, Michel F, Bastide C, Martin N, Baboudjian M. Cost and Environmental Impact of Disposable Flexible Cystoscopes Compared to Reusable Devices. J Endourol 2022; 36:1317-1321. [PMID: 35703325 DOI: 10.1089/end.2022.0201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Objectives: To quantify the environmental impact and costs associated with flexible cystoscopy procedures from an institutional perspective, with particular attention for the comparison between disposable and reusable cystoscopes. Materials and Methods: This is a single-center retrospective study, including all flexible cystoscopies performed between 2020 and 2021 using reusable or single-use devices. The Ambu aS4C single-use cystoscope (Ballerup, Denmark) gradually replaced the reusable device in our center, with exclusive use from October 2021. Reprocessing costs for reusable cystoscopes were evaluated using a micro-costing approach. The environmental impact of reusable and disposable cystoscopes was assessed by the amount of waste and water consumed for each procedure. Results: A total of 1578 flexible cystoscopies using reusable cystoscopes were performed in 2020, and 550 cystoscopies were performed using the Ambu aS4C cystoscope from October 2021 to February 2022. The cost of flexible cystoscopy with a reusable and a disposable endoscope was €196 and €192, respectively. The amount of waste generated by reprocessing reusable and disposable cystoscopes was 800 and 200 g per procedure, respectively. Water consumption for sterilization of the reusable cystoscope was 60 L per procedure, whereas no water consumption was required with the Ambu aS4C cystoscope. A 100% Ambu aS4C cystoscope use would reduce waste generation and water consumption by 946.8 kg and 94.68 m3 per year. Conclusion: In this study, implementing a strategy of using 100% disposable cystoscopes was associated with similar costs and reduced waste generation and water consumption compared to reusable devices. Future studies are needed to compare the carbon footprint of these devices, through a comprehensive and rigorous life cycle assessment from manufacturing to recycling.
Collapse
Affiliation(s)
- Tiphaine Boucheron
- Pharmacy Department, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Eric Lechevallier
- Department of Urology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Bastien Gondran-Tellier
- Department of Urology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Floriane Michel
- Department of Urology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Cyrille Bastide
- Department of Urology, North Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Nathalie Martin
- Pharmacy Department, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
| | - Michael Baboudjian
- Department of Urology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.,Department of Urology, North Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.,Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain
| |
Collapse
|
11
|
Chkir S, Michel F, Akakpo W, Chinier E, Capon G, Peyronnet B, Saussine C, Baron M, Biardeau X, Ruffion A, Gamé X, Denys P, Chartier-Kastler E, Phé V, Karsenty G. Non-continent urinary diversion (ileal conduit) as salvage therapy in patients with refractory lower urinary tract dysfunctions due to multiple sclerosis: results of a national cohort from the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF). Urology 2022; 168:216-221. [PMID: 35768028 DOI: 10.1016/j.urology.2022.06.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 06/10/2022] [Accepted: 06/12/2022] [Indexed: 10/17/2022]
Abstract
OBJECTIVE To describe the outcomes of ileal conduit as a salvage therapy for refractory lower urinary tract dysfunctions (LUTDs) due to multiple sclerosis (MS) in a national neurourology referral center network. METHODS A retrospective multicenter French study was carried out to identify MS patients who underwent non-continent urinary diversion for refractory LUTDs from January 2010 to December 2015. Multiple sclerosis status, urological history, surgical indication and technique, postoperative complications, renal anatomy and function at last follow-up as well as number of rehospitalizations for urinary tract infections (UTI) were collected. Preoperative and postoperative urinary-related quality of life (urQoL) through the QualiveenTM short-form questionnaire (QSFTM) and patient global impression of improvement (PGI-I) were collected and analyzed. RESULTS Overall, 10 centers identified 211 patients with a mean age of 54±11 and mean preoperative EDSS (expanded disability status scale) score of 7.3±0.9. The main indication for diversion was MS progression leading to impossible intermittent self-catheterization (55%). Cystectomy was performed either by open (34.6%), laparoscopic (39.3%) or robotic (21.8%) approach (unknown: 4.2%) with cystectomy in all cases. Early complications were reported in 42% of the patients, mainly Clavien I or II grades. There was no difference in GFR (glomerular filtration rate) after surgery. After diversion, patients had fewer hospitalizations for UTI and better urQoL on QSF™ confirmed by evaluation of PGI-I. CONCLUSION This study, reporting the largest series of ileal conduit in selected MS patients with end-stage LUTDs, showed significant improvement in symptomatic UTI and quality of life with a low high-grade complication rate.
Collapse
Affiliation(s)
- Sadok Chkir
- Urology and Kidney Transplantation, Aix-Marseille University, La Conception Univeristy Hospital, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
| | - Floriane Michel
- Urology and Kidney Transplantation, Aix-Marseille University, La Conception Univeristy Hospital, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
| | - William Akakpo
- Urology, Sorbonne University, Hôpital La pitié Salpétrière, Assistance-Publique Hôpitaux de Paris, Paris, France.
| | - Eva Chinier
- Neuro-Rehabilitation, University of Nantes, Hôpital Saint Jacques, Nantes, France.
| | - Gregoire Capon
- Urology, University of Bordeaux, Hôpital Pellegrin, Bordeaux France.
| | - Benoit Peyronnet
- Urology, University of Rennes, Hôpital Pontchaillou, Renne, France.
| | - Christian Saussine
- Urology, University of Strasbourg, Hôpital Hautepierre, Strasbourg, France.
| | | | | | - Alain Ruffion
- Urology, University Claude Bernard Lyon 1, Hôpital Lyon Sud, HCL, Pierre Bénite, France.
| | - Xavier Gamé
- Urology, University of Toulouse Purpan, Hôpital Rangueil, Toulouse, France.
| | - Pierre Denys
- Urology, Paris Saclay University, neuro-urology unit, Hôpital Raymond Poincaré, AP-HP, Garches, France.
| | - Emmanuel Chartier-Kastler
- Urology, Sorbonne University, Hôpital La pitié Salpétrière, Assistance-Publique Hôpitaux de Paris, Paris, France; Urology, Paris Saclay University, neuro-urology unit, Hôpital Raymond Poincaré, AP-HP, Garches, France.
| | - Véronique Phé
- Urology, Sorbonne University, Tenon Academic Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France.
| | - Gilles Karsenty
- Urology and Kidney Transplantation, Aix-Marseille University, La Conception Univeristy Hospital, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
| |
Collapse
|
12
|
Pirrello J, Sorin G, Dahan S, Michel F, Dany L, Tosello B. Analysis of communication and logistic processes in neonatal intensive care unit. BMC Pediatr 2022; 22:137. [PMID: 35291967 PMCID: PMC8922841 DOI: 10.1186/s12887-022-03209-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2021] [Accepted: 02/14/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In neonatology, parents play a central role as guarantors of the new-born's autonomy. Notifying parents about their infant's status in neonatal critical care is an integral part of the care. However, conveying this information can be very difficult for physicians and the neonatal medical team. The objective of this work is to assess the dimensions and dynamic processes of critical care communications in neonatal intensive care in order to enhance the development of theoretical and applied knowledge of these discussions. METHODS This qualitative, descriptive study was conducted on critical care new-borns less than 28 days-old who were hospitalized in a neonatal intensive care unit. Verbatim communications with the parents were recorded using a dictaphone. RESULTS The verbatim information had five themes: (a) critical care, (b) establishing the doctor-patient relationship, (c) assistance in decision making, (d) Socio-affective and (e) socio-symbolic dimensions. Our recordings underscored both the necessity of communication skills and the obligation to communicate effectively. Analysis of the dynamics of the communication process, according to the categories of delivering difficult information, showed few significant differences. CONCLUSION Physician training needs to include how to effectively communicate to parents to optimize their participation and cooperation in managing their care.
Collapse
Affiliation(s)
- J Pirrello
- Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France.,Department of Neonatal Medicine, North Hospital, Assistance-Publique des Hôpitaux de Marseille, 13015, Marseille, France
| | - G Sorin
- Department of Neonatal Medicine, North Hospital, Assistance-Publique des Hôpitaux de Marseille, 13015, Marseille, France
| | - S Dahan
- Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France
| | - F Michel
- Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France.,Pediatric Intensive Care Unit, Hôpital de la Timone, Assistance-Publique des Hôpitaux de Marseille, 13005, Marseille, France
| | - L Dany
- Aix Marseille University, LPS, Aix-en-Provence, France.,Service of Medical Oncology, Hôpital de la Timone, Assistance-Publique des Hôpitaux de Marseille, 13005, Marseille, France
| | - B Tosello
- Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France. .,Department of Neonatal Medicine, North Hospital, Assistance-Publique des Hôpitaux de Marseille, 13015, Marseille, France.
| |
Collapse
|
13
|
Michel F, Reck H, Schulz H. Generic evaluation of operating experience with regard to the ageing behaviour of passive mechanical components in nuclear power plants. KERNTECHNIK 2022. [DOI: 10.1515/kern-2002-0074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Since the mid-90s, GRS has been dealing systematically with the assessment of the influences of ageing on the safety of nuclear power plants. This also involves the generic evaluation of operating experience. In the following, the procedure, methodological approaches and relevant results are presented in an exemplary manner for passive mechanical components. The results show that the number of events influenced by ageing phenomena that have so far occurred in German plants is low and that measures were taken where necessary to detect, monitor and control any changes due to ageing. As new insights may emerge over time concerning the assessment of the ageing behaviour of the components, it is considered necessary to continue with the ongoing generic evaluation of operating experience in order to obtain timely indications of any safety-relevant changes.
Collapse
|
14
|
Michel F, Cancrini F, Cancel-Tassin G, Gamé X, Huyghe E, Rock A, Léon G, Uzan A, Desfemmes FR, Peyronnet B, Fallot J, Léon P, Rolland E, Perrouin-Verbe MA, Wodey J, Capon G, Karsenty G, Rouprêt M, Cussenot O, Alshehhi H, Comperat E, Phé V. A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology. World J Urol 2022; 40:1939-1947. [PMID: 35138436 DOI: 10.1007/s00345-022-03942-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 01/13/2022] [Indexed: 10/19/2022] Open
Abstract
PURPOSE To establish whether the expression of markers of cell differentiation (CK7, CK14, CK20, GATA3), apoptosis (p53), proliferation (Ki67, STAG2) and peri-tumoural lymphocytes (CD3, CD8), provides specific information about urothelial carcinogenesis in neuro-urological patients with bladder cancer (NBC). METHODS Tissue samples from NBC were retrieved from 15 centres in France and compared to control samples from non neuro-urological patients with bladder cancer (NNBC) and from neuro-urological patients without bladder cancer (NB). The expression of CK7, CK14, CK20, GATA3, p53, Ki67, STAG2, CD3 and CD8 markers was analysed using immunohistochemistry of tissue microarray sections. RESULTS Overall, tissue samples from 124 patients were included in the study (n = 72 NBC, n = 26 NNBC and n = 26 NB). Muscle invasive bladder cancer (MIBC) was found in 52 NBC patients (72.2%) and squamous cell differentiation in 9 (12.5%). In NBC samples, the expression of CK20 and GATA3 was significantly more frequent in NMIBC compared to MIBC (p = 0.015 and p = 0.004, respectively). CK20 and GATA3 were significantly more expressed in NBC compared to NNBC (p < 0.001 and p = 0.010, respectively). The expression of CK14, Ki67, CD3 and CD8 was significantly more frequent in NBC than in NNBC samples (p = 0.005, p < 0.001, p < 0.001 and p < 0.001, respectively). The expression of CD3 and CD8 was similar in NBC and NB samples. CONCLUSION In NBC, markers of basal differentiation, proliferation and peri-tumoural lymphocytes were significantly more expressed compared to NNBC controls. These results suggest the aggressiveness of NBC and the role of chronic inflammation in the carcinogenesis of bladder cancer in neuro-urological patients.
Collapse
Affiliation(s)
- Floriane Michel
- Department of Urology and Kidney Transplantation, Aix-Marseille University, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille, 147 Boulevard Baille, 13005, Marseille, France. .,Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.
| | - Fabiana Cancrini
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy
| | - Géraldine Cancel-Tassin
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Xavier Gamé
- Department of Urology, CHU Rangueil, Université Paul Sabatier Toulouse III, Toulouse, France
| | - Eric Huyghe
- Department of Urology, CHU Rangueil, Université Paul Sabatier Toulouse III, Toulouse, France
| | - Aurélien Rock
- Department of Urology, Groupe Hospitalier de L'Institut Catholique Lillois, Lille, France
| | - Grégoire Léon
- Department of Urology and Transplantation, CHU de Caen, Caen, France
| | - Audrey Uzan
- Department of Urology, Sorbonne University, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | | | | | - Jérémy Fallot
- Department of Urology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
| | - Priscilla Léon
- Department of Urology, Clinique Urologie Royan, Royan, France
| | | | | | - Jacques Wodey
- Department of Urology, Clinique Rhône Durance, Avignon, France
| | - Grégoire Capon
- Department of Urology, University of Bordeaux, Bordeaux, France
| | - Gilles Karsenty
- Department of Urology and Kidney Transplantation, Aix-Marseille University, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille, 147 Boulevard Baille, 13005, Marseille, France
| | - Morgan Rouprêt
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Urology, Sorbonne University, Pitié-Salpêtrière Academic Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Olivier Cussenot
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Urology, Sorbonne University, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Hussa Alshehhi
- Department of Pathology, Sorbonne University, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Eva Comperat
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Pathology, Sorbonne University, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Véronique Phé
- Sorbonne University, GRC5 Predictive Onco-urology, Assistance Publique-Hôpitaux de Paris, Paris, France.,Department of Urology, Sorbonne University, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
15
|
Michel F, Cancrini F, Bensadoun H, Cussenot O, Guillot-Tantay C, Rouprêt M, Karsenty G, Phé V. Incidence of bladder cancer in neuro-urological patients in France: A nationwide study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00240-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
16
|
Faure A, Haddad M, Guys J, Michel F, Merrot T, Karsenty G. Preliminary experience with adjustable periuretral balloons (ACT™) to treat stress urinary incontinence due to intrinsic sphincter deficiency in children. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00729-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Cancrini F, Michel F, Cussenot O, Alshehhi H, Comperat E, Phé V. Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: Are they the same tumors? Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01160-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Michel F, Cancrini F, Cancel-Tassin G, Gamé X, Huyghe E, Rock A, Léon G, Uzan A, Desfemmes FR, Peyronnet B, Fallot J, Léon P, Rolland E, Perrouin-Verbe MA, Wodey J, Capon G, Karsenty G, Rouprêt M, Cussenot O, Alshehhi H, Comperat E, Phé V. A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00175-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Michel F, Cancrini F, Cancel-Tassin G, Compérat E, Karsenty G, Rouprêt M, Cussenot O, Phé V. Tumeurs de vessie sur vessie neurologique en France entre 2013 et 2016 : comparaison à une population de tumeurs sur vessie non neurologique. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Michel F, Bensadoun H, Gaillet S, Boissier R, Delaporte V, Gondran-Tellier B, Chkir S, Baboudjian M, Lechevallier E, Karsenty G. Epidemiology and care pathway of vesicovaginal fistulas managed in France between 2010 and 2018. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00753-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Deledalle FX, Ambrosetti D, Durand M, Michel F, Baboudjian M, Gondran-Tellier B, Lannes F, Daniel L, André M, Fais PO, Savoie PH, Durand X, Rossi D, Karsenty G, Bastide C, Lechevallier E, Boissier R. Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and Feasibility. Urology 2021; 156:185-190. [PMID: 34087310 DOI: 10.1016/j.urology.2021.05.034] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 05/13/2021] [Accepted: 05/19/2021] [Indexed: 01/05/2023]
Abstract
OBJECTIVES To report the outcomes and feasibility of active surveillance (AS) of biopsy-proven renal oncocytomas. METHODS Multicentric retrospective study (2010-2016) in 6 academic centers that included patients with biopsy-proven renal oncocytomas who were allocated to AS (imperative or elective indication) with a follow-up ≥1 year. Imaging was performed at least once a year, by CT-scan or ultrasound or MRI. Conversion to active treatment (surgical excision or ablative treatment) was at the discretion of the urologist. The primary endpoint was renal tumor growth (cm/year). Secondary outcomes included accuracy of biopsy, incidence, and reason to change AS to active treatment. RESULTS Eighty-nine patients were included: Median age 67 years (26-89) and median tumor size 26 mm [15-90] on diagnosis. During a mean follow-up of 43 months'' (median 36 [12-180]), mean tumor growth was 0.24 cm/year. No predictive factors (demographical, radiological or histologic) of tumor growth could be identified. Conversion from AS to active treatment occurred in 24 patients (27%) (13 surgical excisions, 11 ablative procedures), in a median time of 45 (12-76) months'' after diagnosis. Tumor growth was the main indication to convert AS to active treatment (58%) with 8% of the patients opting to discontinue AS. No patient had metastatic progression nor disease-specific death. The correlation between biopsy and surgical specimen was 92%. CONCLUSION Active surveillance for biopsy-proven renal oncocytomas was oncologically safe and patient adherence was high. No predictive factor for tumor growth could be identified but the tumor growth rate was low, and biopsy efficacy was high.
Collapse
Affiliation(s)
| | - Damien Ambrosetti
- Department of Pathology, Nice University, Pasteur University Hospital, Nice, France
| | - Mathieu Durand
- Department of Urology, Nice University, Pasteur University Hospital, Nice, France
| | - Floriane Michel
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France
| | - Michael Baboudjian
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France
| | - Bastien Gondran-Tellier
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France
| | - François Lannes
- Department of Urology, Aix-Marseille University, APHM, Nord University Hospital, Marseille, France
| | - Laurent Daniel
- Department of Pathology, Aix-Marseille University, APHM, La Timone University Hospital, Marseille, France
| | - Marc André
- Department of Radiology, Aix-Marseille University, APHM, La Conception University Hospital, Marseille, France
| | | | | | - Xavier Durand
- Department of Urology, Military Hospital Bégin, Saint Mandé, France
| | - Dominique Rossi
- Department of Urology, Aix-Marseille University, APHM, Nord University Hospital, Marseille, France
| | - Gilles Karsenty
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France
| | - Cyrille Bastide
- Department of Urology, Aix-Marseille University, APHM, Nord University Hospital, Marseille, France
| | - Eric Lechevallier
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France
| | - Romain Boissier
- Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM, Conception University Hospital, Marseille, France.
| |
Collapse
|
22
|
Cremer R, de Saint Blanquat L, Birsan S, Bordet F, Botte A, Brissaud O, Guilbert J, Le Roux B, Le Reun C, Michel F, Millasseau F, Sinet M, Hubert P. Withholding and withdrawing treatment in pediatric intensive care. Update of the GFRUP recommendations. Arch Pediatr 2021; 28:325-337. [PMID: 33875345 DOI: 10.1016/j.arcped.2021.03.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 03/15/2021] [Indexed: 11/29/2022]
Abstract
In 2005, the French-speaking task force on pediatric critical and emergency care [Groupe Francophone de Réanimation et d'Urgences Pédiatriques (GFRUP)] issued recommendations on withholding and withdrawing treatments in pediatric critical care. Since then, the French Public Health Code, modified by the laws passed in 2005 and 2016 and by their enactment decrees, has established a legal framework for practice. Now, 15 years later, an update of these recommendations was needed to factor in the experience acquired by healthcare teams, new questions raised by practice surveys, the recommendations issued in the interval, the changes in legislation, and a few legal precedents. The objective of this article is to help pediatric critical care teams find the closest possible compromise between the ethical principles guiding the care offered to the child and the family and compliance with current regulations and laws.
Collapse
Affiliation(s)
- R Cremer
- Réanimation et soins continus pédiatriques, hôpital Jeanne-de-Flandre, ERER des Hauts-de-France, CHU de Lille, 59037 Lille, France.
| | - L de Saint Blanquat
- Réanimation pédiatrique, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75015 Paris, France
| | - S Birsan
- Unité de soins continus et réanimation néonatale et pédiatrique, hôpital des enfants, CHU Bordeaux, place Amélie-Raba-Léon, 33000 Bordeaux, France
| | - F Bordet
- Réanimation pédiatrique, hôpital Femme-Mère-Enfant, hospices civils de Lyon, 59, boulevard Pinel, 69500 Lyon-Bron, France
| | - A Botte
- Unité de soins continus et réanimation néonatale et pédiatrique, hôpital des enfants, CHU Bordeaux, place Amélie-Raba-Léon, 33000 Bordeaux, France
| | - O Brissaud
- Unité de soins continus et réanimation néonatale et pédiatrique, hôpital des enfants, CHU Bordeaux, place Amélie-Raba-Léon, 33000 Bordeaux, France
| | - J Guilbert
- Réanimation néonatale pédiatrique, hôpital Armand-Trousseau, 26, avenue du Docteur-Arnold-Netter, 75012 Paris, France
| | - B Le Roux
- Réanimation pédiatrique, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France
| | - C Le Reun
- Réanimation pédiatrique, hôpital Clocheville, CHU de Tours, 2, boulevard Tonnelle, 37000 Tours, France
| | - F Michel
- Anesthésie et réanimation pédiatrique, hôpital de la Timone, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| | - F Millasseau
- Réanimation pédiatrique, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France
| | - M Sinet
- Réanimation néonatale pédiatrique, hôpital Armand-Trousseau, 26, avenue du Docteur-Arnold-Netter, 75012 Paris, France; Réanimation et surveillance continue pédiatriques, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France
| | - P Hubert
- Réanimation pédiatrique, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75015 Paris, France
| | | |
Collapse
|
23
|
Atamian A, Sichez PC, Michel F, Bandelier Q, Fall M, Gaillet S, Azoulay JP, Lechevallier E, Karsenty G. [Intradetrusor injections of botulinum toxin A to treat urinary incontinence due to bladder overactivity during idiopathic Parkinson's disease]. Prog Urol 2021; 31:430-438. [PMID: 33579624 DOI: 10.1016/j.purol.2021.01.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Revised: 01/16/2021] [Accepted: 01/18/2021] [Indexed: 11/17/2022]
Abstract
INTRODUCTION During idiopathic Parkinson's disease (IPD), lower urinary tract symptoms and dysfunctions are frequent, dominated by overactive bladder and detrusor overactivity (OAB, DO). Intradetrusor Injection (IDI) of Botulinum Toxin A (BTA) is recommended as second-line treatment for neurogenic urinary incontinence related to DO in multiple sclerosis or spinal cord injury patients. However, there is little data on BTA IDI to treat incontinence owing to OAB and DO during idiopathic Parkinson's disease. The objective of this study is to evaluate efficacy and tolerance of BTA IDI in patients suffering IPD. PATIENTS AND METHODS We conducted a retrospective study in IPD patients treated with BTA IDI from 2012 to 2018. For each patient we compared patient clinical and urodynamic data at baseline before the first injection and 8 weeks following the injection. We defined 3 levels of effects (perfect, improved, failure), corresponding to 3-dimension composite criteria: clinical, quality of life (Likert scale), urodynamics. RESULTS Sixteen patients were included from 2012 to 2018. The median age was 73 (70-78.25). The median number of micturition/day before and after TBA was 13 (10-16) and 9 (6.75-13.25) (p=0.022). The median number of pad used/day before and after BTA was 5.4 (2-5) and 1 (0-5) (p=0.035). Median USP scores for OAB was 15.5 (11.75-20) and 14 (6.75-15.25). Median score on the Likert scale was 1 (0-1.5) meaning "slight improvement" felt by the patient. The median maximum cystometric capacity raised from 130cm3 (41.25-187.75) to 217cm3 (165-376.75) (p=0,013). Among the patients, 20% had a perfect result, 40% were significantly improved and in 40% TBA injections failed. After TBA 4/14 patients (28%) needed intermittent self-catheterization. No severe side effect was observed. CONCLUSION In this retrospective study we observe some short-term efficacy of TBA IDI to treat urinary incontinence owing to OAB/DO in patients with IPD in 60% of patients. These results are consistent with findings from previous retrospective studies. Prospective data coming from larger cohorts are now tremendously needed to clarify the best patient responders profiles, the actual TBA dose, and eventually to define TBA IDI place in the therapeutic algorithm of IPD patients' incontinence. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- A Atamian
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - P C Sichez
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - F Michel
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - Q Bandelier
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - M Fall
- Hôpital Timone, 264, rue Saint-Pierre, 13005 Marseille, France.
| | - S Gaillet
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - J P Azoulay
- Hôpital Timone, 264, rue Saint-Pierre, 13005 Marseille, France.
| | - E Lechevallier
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| | - G Karsenty
- Hôpital Conception, 147, boulevard Baille, 13005 Marseille, France.
| |
Collapse
|
24
|
Baboudjian M, Gondran-Tellier B, Michel F, Abdallah R, Rouy M, Gaillet S, Sichez PC, Boissier R, Bladou F, Lechevallier E, Karsenty G. Miami Pouch: A Simple Technique for Efficient Continent Cutaneous Urinary Diversion. Urology 2021; 152:178-183. [PMID: 33581233 DOI: 10.1016/j.urology.2021.02.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 01/31/2021] [Accepted: 02/01/2021] [Indexed: 10/22/2022]
Abstract
OBJECTIVE To report a contemporary series of Miami pouch (MP) enriched with a full technical description and step-by-step video to contribute to wider use. PATIENTS AND METHODS A retrospective charts review of all patients who had a MP at our center between January 2016 and December 2017 was performed. The MP technique uses the terminal 15cm of ileum and the right colon to build an intestinal heterotopic pouch located in the right iliac fossa and connected to the skin by an efferent catheterizable tube. Primary outcome was continence defined as the absence of leakage between clean intermittent self-catheterization (CISC) with a maximal interval of 4 hours between each CISC. RESULTS Fifteen patients had MP during the study period. Thirty-day postoperative Clavien III complications were observed in 2 (13.3%) patients. At 39 months of median follow-up, continence was obtained for all patients except for 2 patients whom reported intermittent night-time leakages due to long intervals (5 to 7 hours) between 2 CISC. No significant alteration of renal function was reported and no stenosis of the efferent tube neither difficulty to perform CISC was observed. CONCLUSIONS For patients who are candidates for radical cystectomy and not eligible for orthotopic neobladder, intestinal heterotopic pouch with a cutaneous continent urinary diversions as MP may be a reliable alternative. Patients should be informed of the existence of a valid alternative to ileal conduit since it may fit their expectations of a preserved body image without urine collecting appliances.
Collapse
Affiliation(s)
- Michael Baboudjian
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France.
| | - Bastien Gondran-Tellier
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Floriane Michel
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Rony Abdallah
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Mathieu Rouy
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Sarah Gaillet
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Pierre Clement Sichez
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Romain Boissier
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Frank Bladou
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Eric Lechevallier
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| | - Gilles Karsenty
- Aix-Marseille University, APHM, La Conception Academic Hospital, Department of Urology and Renal transplantation, Marseille, France
| |
Collapse
|
25
|
Michel F, Negre T, Baboudjian M, Al-Balushi K, Oliva J, Gondran-Tellier B, Sichez PC, Delaporte V, Gaillet S, Aikiki A, Faure A, Karsenty G, Lechevallier E, Boissier R. Micro-percutaneous nephrolithotomy (Microperc) for renal stones, outcomes and learning curve. Prog Urol 2021; 31:91-98. [DOI: 10.1016/j.purol.2020.03.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2019] [Revised: 12/27/2019] [Accepted: 03/12/2020] [Indexed: 10/24/2022]
|
26
|
Guerzider Regas I, Pluvy I, Tuphe P, Sakek F, Fuchs B, Haight H, Schmitt E, Michel F, Obert L, Lepage D. Long term functional outcomes after minimally invasive surgical decompression in upper limb chronic exertional compartment syndrome in 30 patients. Hand Surgery and Rehabilitation 2021; 40:32-39. [DOI: 10.1016/j.hansur.2020.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 09/17/2020] [Accepted: 09/18/2020] [Indexed: 12/30/2022]
|
27
|
Michel F, Bensadoun H, Gaillet S, Boissier R, Delaporte V, Lechevallier E, Karsenty G. Épidémiologie et parcours de soin des fistules vésicovaginales opérées en France en 2017 à partir de l’analyse du PMSI. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Bandelier Q, Michel F, Boissier R, Gaillet S, Delaporte V, Fasnewindé kaboré A, Lechevallier E, Karsenty G. Résultats des ballons péri-urétraux ajustables (ACT) dans le traitement de l’incontinence urinaire d’effort complexe de la femme adulte. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
29
|
Michel F, Gaillet S, Boissier R, Delaporte V, Ragni-ghazarossian E, Bastide C, Rossi D, Lechevallier E, Karsenty G. Fistules uro-génitales féminines dans un CHU français durant la dernière décennie : description et résultats de la prise en charge. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Michel F, Bensadoun H, Cancrini F, Karsenty G, Phé V. Épidémiologie des tumeurs de vessie sur vessie neurologique opérées entre 2010 et 2018 en France : analyse de la base PMSI. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Vanacore D, Alegorides C, Bigot P, Hardwigsen J, Vidal V, Riberi A, Andre M, Gondran-Tellier B, Baboudjian M, Michel F, Karsenty G, Lechevallier E, Bernhard J, Boissier R. Immediate preoperative renal artery embolization in the resection of complex renal tumors. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35496-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
32
|
Vanacore D, Deledalle F, Ambrosetti D, Durand M, Michel F, Baboudjian M, Gondran-Tellier B, Daniel L, André M, Fais P, Savoie P, Durand X, Rossi D, Karsenty G, Bastide C, Lechevallier E, Boissier R. Active surveillance of biopsy-proven renal oncocytomas, whatever the size at diagnosis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35497-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
33
|
Bonaventure O, De Coninck Q, Duchêne F, Gégo A, Jadin M, Michel F, Piraux M, Poncin C, Tilmans O. Open educational resources for computer networking. SIGCOMM Comput Commun Rev 2020. [DOI: 10.1145/3411740.3411746] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
To reflect the importance of network technologies, networking courses are now part of the core materials of Computer Science degrees. We report our experience in jointly developing an open-source ebook for the introductory course, and a series of open educational resources for both the introductory and advanced networking courses. These ensure students actively engage with the course materials, through a hands-on approach; and scale to the larger classrooms and limited teaching staff, by leveraging open-source resources and an automated grading platform to provide feedback. We evaluate the impact of these pedagogical innovations by surveying the students, who indicated that these were helpful for them to master the course materials.
Collapse
|
34
|
Baboudjian M, Gondran-Tellier B, Di Bisceglie M, Abdallah R, Michel F, Sichez PC, Al-Balushi K, Akiki A, Gaillet S, Delaporte V, Karsenty G, Lechevallier E, Guieu R, Boissier R. The prognostic value of serum procalcitonin in acute obstructive pyelonephritis. World J Urol 2020; 39:1583-1589. [PMID: 32671605 DOI: 10.1007/s00345-020-03353-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 07/07/2020] [Indexed: 10/23/2022] Open
Abstract
PURPOSE To evaluate the prognostic value of procalcitonin (PCT) in the occurrence of infectious complications in the management of acute obstructive pyelonephritis (AOP) compared with other biological parameters (leucocyte count, C-reactive protein [CRP]). METHODS We conducted a retrospective study including patients who were treated for AOP and performed serum PCT tests in our center between January 1, 2017 and December 31, 2017. Upper urinary tract obstruction was confirmed by either ultrasound or CT urography. Clinical examinations and laboratory tests including leukocyte count, CRP, urine and blood cultures, and serum PCT measurements were performed in the emergency unit. Treatment included early renal decompression using indwelling ureteral stents or nephrostomy and empiric antibiotic therapy. The primary endpoint was occurrence of severe sepsis (SS), a composite criterion including urosepsis and/or septic shock and/or admission to the intensive care unit (ICU) and/or death. RESULTS A total of 110 patients (median age: 61 years) were included, of whom 56.3% were female. SS occurred in 39 cases (35.4%). Multivariate regression analysis showed that serum PCT (OR 1.08; 95% CI 1.03-1.17; p = 0.01), CRP (OR 1.007; 95% CI 1.001-1.015; p = 0.03), and diabetes mellitus (OR 5.1; 95% CI 1.27-27.24; p = 0.04) were independent predictors for SS. Serum PCT was the biological marker associated with the highest accuracy to predict SS (ROC 0.912 (95% CI 0.861-0.962) and was superior to CRP (p < 0.001): the sensitivity and specificity of PCT to predict SS were 95% and 77%, respectively, with a serum PCT cutoff value of 1.12 µg/L. CONCLUSIONS PCT levels > 1.12 µg/L could help physicians to identify high-risk patients who could benefit from early and aggressive management in collaboration with intensive care specialists.
Collapse
Affiliation(s)
- Michael Baboudjian
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Bastien Gondran-Tellier
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Mathieu Di Bisceglie
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Rony Abdallah
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Floriane Michel
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Pierre Clement Sichez
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Khalid Al-Balushi
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Akram Akiki
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Sarah Gaillet
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Veronique Delaporte
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Gilles Karsenty
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Eric Lechevallier
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Régis Guieu
- Laboratory of Biochemistry and Molecular Biology, La Timone University Hospital, APHM, Aix-Marseille University, Marseille, France
| | - Romain Boissier
- Department of Urology and Kidney Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France. .,Department of Urology and Renal Transplantation, Conception University Hospital, APHM, Aix-Marseille University, Marseille, France.
| |
Collapse
|
35
|
Baboudjian M, Boissier R, Michel F, Karsenty G, Lechevallier E. Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33154-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
36
|
Eymard F, Ornetti P, Maillet J, Noel E, Adam P, Legré Boyer V, Boyer T, Allali F, Grémeaux Bader V, Kaux JF, Louati K, Lamontagne M, Michel F, Richette P, Bard H. AB0862 CONSENSUS STATEMENT ON INTRA-ARTICULAR INJECTIONS OF PLATELET-RICH PLASMA FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:There has been much debate regarding the use of intra-articular injections of platelet-rich plasma (PRP) as symptomatic treatment for knee osteoarthritis. The heterogeneity of the preparation and injection protocols limits the extrapolation of data from randomized controlled trials and meta-analyses.Objectives:The objective of this expert consensus was to develop the first clinical practice recommendations for PRP injections in knee osteoarthritis.Methods:Fifteen physicians (10 rheumatologists, 4 specialists in rehabilitation and sport medicine and 1 interventional radiologist) from different countries were selected given to their expertise in the fields of PRP and osteoarthritis. Twenty-five recommendations were finally retained after several meetings using the modified Delphi method to establish clinical consensus. All experts voted their agreement or not for each recommendation using a score between 1 (totally inappropriate) and 9 (totally appropriate). Depending on the median value and extreme scores, recommendations were judged as appropriated or unappropriated with a strong or relative agreement but could also be judged as uncertain due to indecision or absence of consensus.Results:The main recommendations are listed below:- Intra-articular injections of PRP constitute an efficient treatment of early or moderate symptomatic knee osteoarthritis. Median = 8 [6-9] – Appropriate. Relative agreement.- Intra-articular injections of PRP may be useful in severe knee osteoarthritis (Kellgren-Lawrence grade IV). Median = 7 [6-7] – Appropriate. Relative agreement.- Intra-articular injections of PRP in knee osteoarthritis should be proposed as second-line therapy, after failure of non-pharmacological and pharmacological (oral and topic) symptomatic treatment. Median = 9 [5-9] – Appropriate. Relative agreement.- Intra-articular injections of PRP should not be performed in osteoarthritis flare-up with significant effusion. Median = 7 [5-9] – Appropriate. Relative agreement.- Intra-articular PRP treatment may include 1 to 3 consecutive injections. Median = 9 [7-9] – Appropriate. Strong agreement.- Leukocyte-poor PRP should be preferred for knee OA treatment. Median = 8 [5-9] – Appropriate. Relative agreement.- PRP injections should be performed under ultrasound or fluoroscopic guidance. Median = 8 [3-9] – Uncertain. No consensus.- PRP should not be mixed with injectable anesthetic or corticosteroid. Median = 9 [6-9] – Appropriate. Relative agreement.Conclusion:Twenty-five recommendations were discussed by an international multidisciplinary task force group in order to provide a basis for standardization of clinical practices and future research protocols.Disclosure of Interests:Florent Eymard Consultant of: Regenlab, Paul Ornetti: None declared, Jérémy Maillet Consultant of: Regenlab, Eric Noel Consultant of: Regenlab, Philippe Adam Consultant of: Regenlab, Virginie Legré Boyer Consultant of: Regenlab, Thierry Boyer Consultant of: Regenlab, Fadoua Allali: None declared, Vincent Grémeaux Bader: None declared, Jean-François Kaux: None declared, Karine Louati: None declared, Martin Lamontagne Consultant of: Pendopharm, Fabrice Michel: None declared, Pascal Richette: None declared, Hervé Bard Consultant of: Regenlab
Collapse
|
37
|
Baboudjian M, Bandelier Q, Gondran-Tellier B, Abdallah R, Michel F, Sichez PC, Di-Crocco E, Akiki A, Gaillet S, Delaporte V, Andre M, Daniel L, Karsenty G, Lechevallier E, Boissier R. MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate? Int Urol Nephrol 2019; 52:611-618. [DOI: 10.1007/s11255-019-02353-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Accepted: 11/25/2019] [Indexed: 10/25/2022]
|
38
|
Grimaldi C, Michel F, Brévaut-Malaty V, Hassid S, Nicaise C, Puech B, Thomachot L, Vialet R, Tosello B, Panuel M. Thoracic ultrasound accuracy for the investigation of initial neonatal respiratory distress. Arch Pediatr 2019; 26:459-465. [DOI: 10.1016/j.arcped.2019.09.009] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Revised: 07/01/2019] [Accepted: 09/22/2019] [Indexed: 11/25/2022]
|
39
|
Gondran-Tellier B, Boissier R, Baboudjian M, Rouy M, Gaillet S, Lechevallier E, Michel F, Karsenty G. Robot-assisted implantation of an artificial urinary sphincter, the AMS-800, via a posterior approach to the bladder neck in women with intrinsic sphincter deficiency. BJU Int 2019; 124:1077-1080. [PMID: 31365772 DOI: 10.1111/bju.14884] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES To describe a new technique for robot-assisted AMS-800 artificial urinary sphincter (AUS) bladder neck implantation in women. PATIENTS AND METHODS We reviewed the medical files of patients who underwent robot-assisted AUS implantation between March 2017 and November 2018 at our centre. All of the implantations were performed using a posterior approach to the bladder neck in order to avoid blind dissection and the risk of vaginal and/or bladder injury. This strategy was viewed as an alternative to the anterior robot-assisted implantation recently described. The AUSs were activated 5 weeks after implantation. Patients were followed up at 3, 6 and 12 months, then annually. RESULTS Eight patients, with a median age of 64 years, underwent robot-assisted AUS implantation via a posterior approach to the bladder neck. The median preoperative pad weight was 300 g/24 h. The median operating time was 244 min. No peri-operative vaginal and or bladder injuries were observed. At a median of 12 months of follow-up, all the AUSs were functional. Five patients required no protection (62.5%), three had day protection (37.5%), and all said they were satisfied except for one patient (12.5%) who requested treatment for persistent urge incontinence. CONCLUSION Robot-assisted AUS implantation in women via a posterior approach to the bladder neck is a procedure that is simple, reproducible and safe. The short-term functional results are satisfactory and comparable to those obtained via an open approach. A more long-term comparison of the efficacy and longevity of AUSs implanted using this posterior approach is needed to confirm its benefit compared with the anterior robot-assisted approach and the classic open technique.
Collapse
Affiliation(s)
- Bastien Gondran-Tellier
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Romain Boissier
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Michael Baboudjian
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Mathieu Rouy
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Sarah Gaillet
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Eric Lechevallier
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Floriane Michel
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| | - Gilles Karsenty
- Urology and Kidney Transplantation Department, La Conception Hospital, Aix Marseille University, Marseille, France
| |
Collapse
|
40
|
Abstract
The findings of functional endoscopy (upper esophageal sphincter insufficiency, cardia insufficiency, esophagitis, gastric heterotopia, axial sliding hernia, and visible aerosols) can be traced back to pharyngeal acid exposure by oropharyngeal pH measurement. Significantly increased pharyngeal acid loads are seen in gastric heterotopy and axial sliding hernia. For all measured statistics, the pharyngeal acid load is in the pathological or even very pathological range. The value of functional endoscopy in the context of laryngopharyngeal reflux diagnosis is clearly documented. The findings "heterotopic gastric mucosa" and "axial sliding hernia" may cause marked airway symptoms and a pathogenetic relationship with otorhinolaryngologic reflux-associated symptoms must be postulated for these entities.
Collapse
Affiliation(s)
- F Michel
- HNO-Praxis im Kreiskrankenhaus, Hauptstraße 30, 64342, Seeheim-Jugenheim, Deutschland.
| | | | - T Stroh
- Refluxzentrum Darmstadt, Darmstadt, Deutschland
| | - R Fritsche
- Refluxzentrum Darmstadt, Darmstadt, Deutschland
| | - P Ahrens
- Refluxzentrum Darmstadt, Darmstadt, Deutschland
| |
Collapse
|
41
|
Al-Balushi K, Martin N, Loubon H, Baboudjian M, Michel F, Sichez PC, Martin T, Di-Crocco E, Gaillet S, Delaporte V, Akiki A, Faure A, Karsenty G, Lechevallier E, Boissier R. Comparative medico-economic study of reusable vs. single-use flexible ureteroscopes. Int Urol Nephrol 2019; 51:1735-1741. [PMID: 31317310 DOI: 10.1007/s11255-019-02230-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Accepted: 07/08/2019] [Indexed: 11/30/2022]
Abstract
PURPOSE Reusable flexible-ureteroscopes (fURS) require personnel and budget for processing and repairing, whereas single-use fURS were recently developed. After exclusive reusable fURS since 2011, we experienced high repair costs and single-use fURS were therefore introduced in mid-2017. We aimed to evaluate economic and practical advantages and disadvantages of reusable versus single-use fURS. MATERIALS AND METHODS First, we evaluated the incidence of breakage and repairs of reusable fURS in 2017. We assessed the overall operational costs of reusable fURS including purchase, processing, and repairing in our institution from 2011 to 2017. Following our experience, we created a model to compare operation costs/procedure of single-use fURS with reusable fURS depending on repair costs. RESULTS In 2017, repair costs of reusable fURS increased by 345% compared with the period 2011-2016, causing: a median unavailability per reusable fURS of 200 days/year (100-249), median number of functioning fURS 0/5-3/5 per operating day, while unavailability of reusable fURS had become the first reason for cancellation of procedure. Since it was introduced, single-use fURS accounted for 59% of the flexible ureteroscopy activity. Taking into account the costs of processing, maintenance and repair, in 2011-2016 versus 2017, the single-use fURS was cost-effective compared with the reusable fURS until the 22nd procedure versus the 73rd procedure, respectively. CONCLUSIONS After years of exclusive reusable fURS, the rising incidence of breakage not only increased maintenance costs but also hampered daily activity owing to unavailability of the devices. The introduction of single-use with reusable fURS provided substantial help to maintain our activity.
Collapse
Affiliation(s)
- Khalid Al-Balushi
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Nathalie Martin
- APHM, Conception University Hospital, Central Pharmacy, Marseille, France
| | - Hélène Loubon
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Michael Baboudjian
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Floriane Michel
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Pierre-Clément Sichez
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Thomas Martin
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Eugénie Di-Crocco
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Sarah Gaillet
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Veronique Delaporte
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Akram Akiki
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Alice Faure
- Department of Pediatric Surgery, APHM, Timone University Hospital, Aix-Marseille University, Marseille, France
| | - Gilles Karsenty
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Eric Lechevallier
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France
| | - Romain Boissier
- Department of Urology and Kidney Transplantation, APHM, Conception University Hospital, Aix-Marseille University, 13005, Marseille, France.
| |
Collapse
|
42
|
Michel F, Ciceron C, Bernuz B, Boissier R, Gaillet S, Even A, Chartier-Kastler E, Denys P, Gamé X, Ruffion A, Normand LL, Perrouin-Verbe B, Saussine C, Manunta A, Forin V, De Seze M, Grise P, Tournebise H, Schurch B, Karsenty G. Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study. Urology 2019; 129:43-47. [DOI: 10.1016/j.urology.2019.03.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2018] [Revised: 03/09/2019] [Accepted: 03/12/2019] [Indexed: 11/25/2022]
|
43
|
Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt C, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar J, Bruyère R, Chanques G. Pneumonies associées aux soins de réanimation* RFE commune SFAR–SRLF. Méd Intensive Réa 2019. [DOI: 10.3166/rea-2019-0106] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
44
|
Belachew N, Jerkic S, Michel F, Schubert R, Zielen S, Rosewich M. Lungenfunktion, Lung Clearance Index und bronchiale Entzündung bei Kindern und Jugendlichen mit Bronchiolitis obliterans. Pneumologie 2019; 73:399-406. [DOI: 10.1055/a-0853-0253] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Zusammenfassung
Einleitung Die Bronchiolitis obliterans (BO) ist eine sehr seltene, chronische Lungenerkrankung, die vereinzelt nach schweren Atemwegsinfektionen oder als Folge von Stammzell- und Lungentransplantation auftritt. Ziel der Arbeit war es, die Lungenfunktion und die bronchiale Entzündung bei BO-Patienten im Jugend- und Kindesalter zu untersuchen. Zudem sollte das Potenzial des LCI in der Diagnostik dieser Patienten untersucht werden.
Methoden Es wurden 16 BO-Patienten (Alter: Median 16,7; 9,6 – 25,3 Jahre) und 17 gesunde Probanden (Alter: Median 16,6; 7,6 – 25,0 Jahre) untersucht. Neben der Untersuchung der Lungenfunktion (FVC, FEV1, MEF25, RV und RV/TLC) mittels Bodyplethysmografie erfolgte eine Reversibilitätstestung nach Gabe von 400 µg Salbutamol. Die Bestimmung des LCI erfolgte mittels Multiple Breath Washout (MBW)-Methode. Zusätzlich wurde die Zellverteilung und das Zytokinprofil (IL-1ß, IL-6, IL-8, TNF-α) mittels Cytometric Bead Array (CBA) im induzierten Sputum analysiert.
Ergebnisse FVC, FEV1 und MEF25 der BO-Patienten waren signifikant niedriger, das RV und die RV/TLC jedoch signifikant erhöht im Vergleich zur Kontrollgruppe. Eine bronchiale Reversibilität zeigte sich bei 3 Patienten. Der LCI war bei den BO-Patienten gegenüber der Kontrollgruppe signifikant erhöht (Median 10,24 vs. 7,1) und korrelierte signifikant mit dem MEF25 (p < 0,0001). Im induzierten Sputum fand sich eine signifikante Erhöhung der Gesamtzellzahl, der neutrophilen Granulozyten sowie von IL-6 und IL-8 (p < 0.01).
Schlussfolgerung Die Lungenfunktion ist bei Kindern und Jugendlichen mit BO stark eingeschränkt. Zudem erwies sich der LCI als sensitiver und reproduzierbarer Marker zur Beurteilung der obstruktiven Beeinträchtigung der kleinen Atemwege. Im induzierten Sputum ist eine von Neutrophilen dominierte bronchiale Entzündung nachweisbar.
Collapse
Affiliation(s)
- N. Belachew
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| | - S. Jerkic
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| | - F. Michel
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| | - R. Schubert
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| | - S. Zielen
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| | - M. Rosewich
- Klinik für Kinder- und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose
| |
Collapse
|
45
|
Baboudjian M, Lechevallier E, Michel F, Ben Othman K, Martin T, Di Crocco E, Akiki A, Gaillet S, Delaporte V, Karsenty G, Boissier R. [Does diagnostic ureterorenoscopy increase the risk of bladder recurrence after total nephroureterectomy? A review of the literature]. Prog Urol 2019; 29:138-146. [PMID: 30846356 DOI: 10.1016/j.purol.2019.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 11/04/2018] [Accepted: 02/01/2019] [Indexed: 10/27/2022]
Abstract
OBJECTIVE The objective of our study was to evaluate, in a review of the literature, the impact of diagnostic ureteroscopy before total nephroureterectomy (NUT) on the risk of bladder recurrence. METHODS We conducted a literature review in the Pubmed database in March 2018. Initial research identified 45 publications. Following full text screening, 9 studies were finally included, with a total of 1041 NUT with URS prior versus 2909 NUT alone. The primary endpoint was bladder recurrence. Secondary objectives were specific survival and overall survival. RESULTS Bladder recurrence was reported in the 9 studies included. Diagnostic ureteroscopy was significantly associated with an increased risk of post-NUT bladder recurrence (HZ 1.42 [1.29-1.56], P<0.01). The specific survival and overall survival at 5 years, were reported in respectively 4 and 2 studies. There was no impact of the pre-NUT diagnostic URS on the specific survival (HZ 0.75 [0.54-1.03], P=0.08) or post-NUT overall survival (HZ 1.15 [0.68-1.96], P=0.59). CONCLUSION The URS diagnostic before NUT for TVEUS is associated with a significant increase in the risk of postoperative bladder recurrence.
Collapse
Affiliation(s)
- M Baboudjian
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.
| | - E Lechevallier
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - F Michel
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - K Ben Othman
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - T Martin
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - E Di Crocco
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - A Akiki
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - S Gaillet
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - V Delaporte
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - G Karsenty
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| | - R Boissier
- Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France
| |
Collapse
|
46
|
Decavel P, Michel F, Moulin T, Parratte B, Sagawa Junior Y. Does fampridine overpass gait cut-offs based on minimal detectable change? Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Aleton E, Sagawa Y, Droz-Bartholet F, Michel F, Decavel P. Effectiveness of functional electrical stimulation of gait. Evaluating of modifications to the center of pressure for a hemiparetic patient. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Quintard H, l’Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille A, Alves M, Gayat E, Donetti L. Intubation and extubation of the ICU patient. Anaesth Crit Care Pain Med 2017; 36:327-341. [DOI: 10.1016/j.accpm.2017.09.001] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
49
|
Michel B, Nonon C, Sercombe J, Michel F, Marelle V. Simulation of Pellet-Cladding Interaction with the PLEIADES Fuel Performance Software Environment. NUCL TECHNOL 2017. [DOI: 10.13182/nt13-a16424] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- B. Michel
- DEC/SESC bat 151 CEA de Cadarache 13108 Saint Paul Lez Durance France
| | - C. Nonon
- DEC/SESC bat 151 CEA de Cadarache 13108 Saint Paul Lez Durance France
| | - J. Sercombe
- DEC/SESC bat 151 CEA de Cadarache 13108 Saint Paul Lez Durance France
| | - F. Michel
- DEC/SESC bat 151 CEA de Cadarache 13108 Saint Paul Lez Durance France
| | - V. Marelle
- DEC/SESC bat 151 CEA de Cadarache 13108 Saint Paul Lez Durance France
| |
Collapse
|
50
|
Mathevon L, Michel F, Aubry S, Testa R, Lapole T, Arnaudeau LF, Fernandez B, Parratte B, Calmels P. Two-dimensional and shear wave elastography ultrasound: A reliable method to analyse spastic muscles? Muscle Nerve 2017; 57:222-228. [DOI: 10.1002/mus.25716] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Revised: 05/26/2017] [Accepted: 05/27/2017] [Indexed: 11/11/2022]
Affiliation(s)
- Laure Mathevon
- Department of Physical and Rehabilitation Medicine; Saint-Etienne University Hospital; Saint-Etienne France
| | - F. Michel
- Department of Physical and Rehabilitation Medicine; Besançon University Hospital; Besançon France
| | - S. Aubry
- Department of Musculoskeletal Imaging; Besançon University Hospital; Besançon France
| | - R. Testa
- Laboratoire Interuniversitaire de biologie de la Motricité; University of Lyon, UJM-Saint-Etienne; Saint-Etienne France
| | - T. Lapole
- Laboratoire Interuniversitaire de biologie de la Motricité; University of Lyon, UJM-Saint-Etienne; Saint-Etienne France
| | - L. F. Arnaudeau
- Laboratoire Interuniversitaire de biologie de la Motricité; University of Lyon, UJM-Saint-Etienne; Saint-Etienne France
| | - B. Fernandez
- Department of Physical and Rehabilitation Medicine; Saint-Etienne University Hospital; Saint-Etienne France
| | - B. Parratte
- Department of Anatomy; University of Franche-Comté; Besançon France
| | - P. Calmels
- Department of Physical and Rehabilitation Medicine; Saint-Etienne University Hospital; Saint-Etienne France
| |
Collapse
|